Organon And Co

This study tested three different doses of a hormonal intrauterine system (IUD) that releases etonogestrel, comparing them to a standard copper IUD for birth control. The trial involved 84 healthy women who had given birth at least once. Researchers looked at safety, how well the…

This study looked at whether the etonogestrel birth control implant, which is approved for 3 years, can safely prevent pregnancy for up to 5 years. About 500 women aged 35 or younger who already had the implant for 3 years took part. Researchers tracked pregnancy rates and side e…

This study tested whether adding ezetimibe early to atorvastatin works better than atorvastatin alone for lowering LDL (bad) cholesterol in people at very high risk for heart problems. It involved 137 adults with atherosclerotic cardiovascular disease. The goal was to see if the …

This study tested three doses of a new drug, OG-6219, in 354 women aged 18 to 49 with moderate to severe endometriosis-related pelvic pain. The goal was to see if the drug reduces overall pelvic pain and to check for side effects. Participants took the drug or a placebo for sever…

This study tested a cream called tapinarof for people aged 2 and older with moderate to severe eczema (atopic dermatitis). Over 400 participants applied the cream or a placebo daily for 8 weeks. The main goal was to see if the cream could make skin clear or almost clear. The stud…

This study tested a cream called tapinarof in 407 children and adults with moderate to severe atopic dermatitis (eczema). The goal was to see if the cream could clear or almost clear the skin rash by 8 weeks compared to a placebo cream. Participants applied the cream daily, and d…

This study looked at how safe a new cream called tapinarof is for children aged 2 to 17 with moderate to severe eczema covering large areas of their body. Researchers checked for side effects and measured how much of the drug got into the bloodstream. The goal was to see if the c…